Clio M

Biography

Dr. Mavragani received her MD and PhD degrees, both with honors, from the National University of Athens, Greece. She also received a Diploma Degree in Internal Medicine from Imperial College, University of London with distinction. She was trained in Rheumatology at the Department of Pathophysiology, University of Athens under the mentorship of Professor HM Moutsopoulos). Fοllowing her clinical fellowship, she joined the lab of Peggy Crow at Hospital for Special Surgery in New York as a recipient of S. Niarchos Foundation International Exchange Fellowship. Her research focuses on the activation of type I IFN system in systemic autoimmune disorders, including Sjogren’s syndrome and systemic lupus erythematosus, the interactions between TNF and IFNs pathways, the potential role of type I interferons as biomarkers of response in patients with rheumatoid arthritis receiving anti-TNF therapies as well as the molecular pathways leading to Sjogren’s syndrome related lymphomagenesis. Dr. Mavragani received her MD and PhD degrees, both with honors, from the National University of Athens, Greece. She also received a Diploma Degree in Internal Medicine from Imperial College, University of London with distinction. She was trained in Rheumatology at the Department of Pathophysiology, University of Athens under the mentorship of Professor HM Moutsopoulos). Fοllowing her clinical fellowship, she joined the lab of Peggy Crow at Hospital for Special Surgery in New York as a recipient of S. Niarchos Foundation International Exchange Fellowship. Her research focuses on the activation of type I IFN system in systemic autoimmune disorders, including Sjogren’s syndrome and systemic lupus erythematosus, the interactions between TNF and IFNs pathways, the potential role of type I interferons as biomarkers of response in patients with rheumatoid arthritis receiving anti-TNF therapies as well as the molecular pathways leading to Sjogren’s syndrome related lymphomagenesis.

Research Interest

Sjogren’s syndrome, Autoimmune diseases, interferon pathways, lymphomagenesis